U.S., Sept. 17 -- ClinicalTrials.gov registry received information related to the study (NCT07175285) titled 'A Study in Participants With Active Systemic Lupus Erythematosus With Inadequate Response to Glucocorticoids and >=2 Immunosuppressants' on Sept. 09.
Brief Summary: The purpose of this study is to characterize the efficacy and safety of current standard of care treatment options in participants with active systemic lupus erythematosus (SLE; including lupus nephritis) with inadequate response to glucocorticoids and at least two immunosuppressants
Study Start Date: Nov. 04
Study Type: OBSERVATIONAL
Condition:
Systemic Lupus Erythematosus (SLE)
Intervention:
DRUG: Current standard of care treatment options
According to the prod...